PROSPR Overview

National Cancer Institute (NCI) established the PROSPR program in September 2011. PROSPR’s overall purpose is to promote coordinated, multidisciplinary research to evaluate and improve the cancer screening process for breast, colon, and cervical cancer.

The objectives are to:
1. Study the comparative effectiveness of existing and emerging screening processes in community practice;
2. Study the balance of benefits and harms across recognized cancer risk profiles;
3. Conduct preliminary studies to inform future research to optimize screening processes and outcomes; and
4. Actively share data and findings with potential collaborators through publications, web portals, and interaction with a consulting panel in order to foster
    related research.

In order to accomplish these objectives, NCI has funded the following institutions to serve as PROSPR Research Centers (PRCs):

  • Kaiser Foundation Research Institute (cervical)
  • Kaiser Foundation Research Institute (colorectal)
  • Kaiser Permanente Washington Health Research Institute (cervical)
  • Kaiser Permanente Washington Health Research Institute (colorectal)
  • Parkland - UT Southwestern (cervical)
  • Parkland - UT Southwestern (colorectal)
  • The Geisel School of Medicine at Dartmouth and Brigham and Women's Hospital (breast)
  • University of New Mexico (cervical)
  • University of Pennsylvania (breast)
  • University of Vermont (breast)

For a list of Principal Investigators and specific aims for each institution, click here

In addition to the PRCs, Fred Hutchinson Cancer Research Center (FHCRC) serves as the PROSPR Statistical Coordinating Center (SCC), with William Barlow, PhD, and Mark Thornquist, PhD, serving as the Principal Investigators.